Several studies have observed that the immune response in insects can be conserved, a phenomenon known as immune priming, which has been mostly tested in adult stages. However, it is unknown if induction of immune priming in larval stages protects against dengue virus (DenV) infections in adult mosquitoes. In this work, we primed larval instar 3 rd of Aedes aegypti with inactive dengue virus, producing adult mosquitoes with i) an enhanced antiviral-immune response; ii) a reduction in the load and replication of RNA of dengue virus (DENV); iii) a decline in viral infective particles production. Adult mosquitoes previously primed during larval stages over-expressed RNA interference (RNAi) markers Argonaute-2 (AGO-2) and Dicer-2 (DCR-2). We also observed inter-individual variations of DENV infection in adult mosquitoes, indicating a heterogeneous response to DENV infection in the same mosquito strain. However, mosquitoes primed during larval stages appear to control the infection, reducing the viral load. The over-expression of interferon-like factors (VAGO) and AGO-2 in the pupa stage suggests a fast activation of antiviral mechanisms after immune priming in larvae, creating a condition in which adult mosquitoes are resistant to the pathogen in the posterior exposure. Aedes aegypti is the primary vector of dengue virus (DENV). It is responsible for an estimated 390 million human infections each year 1,2. The vaccine lacking to prevent the infection in humans, and the mosquito resistance to different insecticides, make it urgent to develop new strategies to interrupt the transmission by this mosquito 3,4. Immune priming has become an important strategy to induce a protective condition against different pathogens in insects, occurring when a primary infectious exposure leads to an immune response that is enhanced upon re-exposure. This phenomenon has been described in various invertebrate taxa, including mosquitoes 3,4. Recent work by our group has analyzed the ability of Ae. aegypti to mount enhanced antiviral responses upon secondary oral DENV immune challenges. Following priming with a live or inactive virus, secondary DENV infections were shown to diminish in midguts and carcasses 5. Also, higher de novo midgut DNA synthesis was detected in challenged tissues, as determined by the incorporation of 5-bromo-2-deoxyuridine (BrDU) in DNA. Endoreplication, a type of de novo DNA synthesis, was shown to correlate with the activation of the Notch pathway, where Hindsight, Delta, and Notch were overexpressed after a secondary challenge with active DENV, in primed Ae. aegypti mosquitoes 6. These findings open a new perspective on the mechanisms underlying the vector's antiviral immune response and the effector molecules involved. Similar results have been observed in Anopheles albimanus 7 , in the LSB-AA695BB cell line (An. albimanus) and trained monocytes 8. The induction of this immune response could be difficult to carry out in the field. Therefore, it is essential to determine if we can activate the immune response in ...